Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00692276 · ClinicalTrials.gov registry record · NA
Investigating Superion™ In Spinal Stenosis
A NA study, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- NA
- Development phase
- 391
- Enrollment target
NCT00692276 is a NA study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 391 participants.
The verdict
NCT00692276, a NA study, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 391 participants
- Enrollment target
Study Summary
The proposed prospective, multi-center, randomized clinical trial is designed to evaluate the safety and effectiveness of the Superion™ ISS compared to the X-STOP® IPD® device in healthy adults suffering from at least 6 months of moderate spinal stenosis symptoms who have been unresponsive to conservative care.
Interventions
- DEVICE Superion™ Interspinous Spacer
- DEVICE X-STOP® IPD® Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 391 participants |
| Start Date | 2008-06 |
| Est. Completion | 2017-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00692276
The ClinicalTrials.gov registry entry for NCT00692276 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 391 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Superion™ Interspinous Spacer is the first listed.
NCT00692276 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00692276 about?
NCT00692276 is a clinical study titled "Investigating Superion™ In Spinal Stenosis". The proposed prospective, multi-center, randomized clinical trial is designed to evaluate the safety and effectiveness of the Superion™ ISS compared to the X-STOP® IPD® device in healthy adults suffering from at least 6 months of moderate spinal stenosis symptoms who have been unresponsive to conser...
What is the current status of trial NCT00692276?
This trial is currently completed. It is a NA study. The enrollment target is 391 participants. The study started on 2008-06. Estimated completion is 2017-02.
What interventions are being tested in trial NCT00692276?
The interventions under investigation include: Superion™ Interspinous Spacer (DEVICE), X-STOP® IPD® Device (DEVICE).
Who is sponsoring clinical trial NCT00692276?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.